Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO

Stock Track

7小时前

SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.

The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.

SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1152577895"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1152577895\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1152577895?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-07 01:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1152577895","market":"us","top_or_hot":-1,"title":"Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO","media":"Stock Track","content":"<p>SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.</p><p>The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.</p><p>SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | SpyGlass Pharma Soars 50% in Intraday Trading on Nasdaq Debut After $150 Million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-07 01:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.</p><p>The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.</p><p>SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SGP","symbol_name":"SpyGlass Pharma Inc","start_time":0,"source_url":"","article_id":"1152577895","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1152577895","pubTimestamp":1770398971,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.The biopharmaceutical company recently completed a $150...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SGP":"SpyGlass Pharma Inc"},"translate_title":"个股追踪|Spyglass Pharma 1.5亿美元IPO后纳斯达克首秀盘中大涨50%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SGP":1},"content_text":"SpyGlass Pharma, Inc. (SGP) saw its stock price soar 50.00% during intraday trading on Friday, marking a strong debut on the Nasdaq exchange.The biopharmaceutical company recently completed a $150 million initial public offering, pricing 9.4 million shares at $16 each. Market indications suggested the stock would open significantly above its IPO price, reflecting strong investor interest in the company's innovative drug delivery systems for chronic eye diseases.SpyGlass Pharma's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery, offering long-acting therapy options. The company's successful IPO and market debut highlight investor confidence in its technology and growth potential in the ophthalmology sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}